# Impact of Midodrine Administration on the Clinical Outcome of Septic Shock Patients

> **NCT03911817** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Midodrine

## Key facts

- **NCT ID:** NCT03911817
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-15
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-07-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911817, "Impact of Midodrine Administration on the Clinical Outcome of Septic Shock Patients". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03911817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*